Research / ADI / Fundamental state Inspectable configuration
State dimensions Filing 0000006281-22-000020 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
233.84% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 38th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.14% · OPTIONAL · VALID
Operating cash generation 23th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
31.90% · OPTIONAL · VALID
Share-count growth 89th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.shares_outstanding
41.86% · CORE · VALID
Revenue growth 100th Own-history percentile · N=9
Evidence method Yoy · gp.fundamentals.revenue
72.24% · CORE · VALID
Inventory pressure 31th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
36.23% · OPTIONAL · VALID
Gross margin 0th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.gross_margin
52.23% · CORE · VALID
Operating margin 0th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.operating_margin
13.59% · CORE · VALID
R&D intensity 0th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
15.90% · OPTIONAL · VALID
SBC intensity 92th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.24% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 32 states Self-history eligible
Oct 30, 2021 9/9 normalized Level 3 Jan 29, 2022 9/10 normalized Level 3 Apr 30, 2022 9/10 normalized Level 3 Jul 30, 2022 9/10 normalized Level 3 Oct 29, 2022 9/9 normalized Level 3 Jan 28, 2023 9/10 normalized Level 3 Apr 29, 2023 9/10 normalized Level 3 Jul 29, 2023 9/10 normalized Level 3 Oct 28, 2023 9/10 normalized Level 3 Feb 3, 2024 9/10 normalized Level 3 May 4, 2024 10/10 normalized Level 3 Aug 3, 2024 10/10 normalized Level 3 Nov 2, 2024 10/10 normalized Level 3 Feb 1, 2025 10/10 normalized Level 3 May 3, 2025 10/10 normalized Level 3 Aug 2, 2025 10/10 normalized Level 3 Nov 1, 2025 10/10 normalized Level 3 Jan 31, 2026 10/10 normalized Level 3 May 2, 2026 10/10 normalized Level 3 Aug 1, 2026 10/10 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 4.70%
Current 4.14%
Delta -0.56% Cash Generation Decreased
Previous 37.37%
Current 31.90%
Delta -5.47% Dilution Decreased
Previous 42.18%
Current 41.86%
Delta -0.32% Growth Increased
Previous 30.61%
Current 72.24%
Delta 41.63% Inventory Pressure Increased
Previous 16.41%
Current 36.23%
Delta 19.83% Margin Decreased
Previous 61.83%
Current 52.23%
Delta -9.60% Profitability Decreased
Previous 23.12%
Current 13.59%
Delta -9.53% R And D Intensity Decreased
Previous 17.71%
Current 15.90%
Delta -1.81% Sbc Intensity Decreased
Previous 3.33%
Current 3.24%
Delta -0.09% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.